Search Results

There are 5133 results for: content related to: A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice

  1. Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies

    Clinical & Laboratory Haematology

    Volume 25, Issue 6, December 2003, Pages: 383–391, H. Nakajima, M. Oki, K. Kishi, Jun-ichi Ueyama, S. Miyakoshi, N. Hatsumi, T. Sakura, S. Miyawaki, A. Yokota, S. Fujisawa, S. Mori, Y. Tanaka, H. Sakamaki and for Kanto Study Group for Cell Therapy (KSGCT)

    Article first published online : 27 NOV 2003, DOI: 10.1046/j.0141-9854.2003.00550.x

  2. An overview of conditioning regimens for haploidentical stem cell transplantation with post-transplantation cyclophosphamide

    American Journal of Hematology

    Volume 90, Issue 6, June 2015, Pages: 541–548, Munira Shabbir-Moosajee, Lindsey Lombardi and Stefan O. Ciurea

    Article first published online : 29 APR 2015, DOI: 10.1002/ajh.23995

  3. Nonmyeloablative Therapy and Hematopoietic Cell Transplantation for Hematologic Disorders

    Thomas' Hematopoietic Cell Transplantation, Third Edition

    Brenda M. Sandmaier, Rainer Storb, Pages: 1164–1176, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987070.ch85

  4. Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

    Cancer

    Jennifer E. Vaughn, Mohamed L. Sorror, Barry E. Storer, Thomas R. Chauncey, Michael A. Pulsipher, Richard T. Maziarz, Michael B. Maris, Parameswaran Hari, Ginna G. Laport, Georg N. Franke, Edward D. Agura, Amelia A. Langston, Andrew R. Rezvani, Rainer Storb, Brenda M. Sandmaier and David G. Maloney

    Article first published online : 24 JUL 2015, DOI: 10.1002/cncr.29498

  5. You have free access to this content
    Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

    American Journal of Hematology

    Volume 83, Issue 7, July 2008, Pages: 563–569, Tania N. Masmas, Søren L. Petersen, Hans O. Madsen, Lars P. Ryder, Brian Kornblit, Arne Svejgaard, Pernille Andersen, Ebbe Dickmeiss and Lars L. Vindeløv

    Article first published online : 13 FEB 2008, DOI: 10.1002/ajh.21168

  6. You have free access to this content
    Review article: stem cell therapies for inflammatory bowel disease – efficacy and safety

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 939–952, O. García-Bosch, E. Ricart and J. Panés

    Article first published online : 19 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04439.x

  7. You have free access to this content
    Nonmyeloablative Conditioning Generates Autoantigen-Encoding Bone Marrow That Prevents and Cures an Experimental Autoimmune Disease

    American Journal of Transplantation

    Volume 12, Issue 8, August 2012, Pages: 2062–2071, Z. Nasa, J.-Y. Chung, J. Chan, B.-H. Toh and F. Alderuccio

    Article first published online : 13 JUN 2012, DOI: 10.1111/j.1600-6143.2012.04068.x

  8. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation

    Transfusion

    Volume 43, Issue 8, August 2003, Pages: 1153–1161, Nina Worel, Peter Kalhs, Felix Keil, Erika Prinz, Karin Moser, Axel Schulenburg, Margit Mitterbauer, Christine Mannhalter, Wolfgang R. Mayr, Ilse Schwarzinger, Paul Höcker, Klaus Lechner and Hildegard T. Greinix

    Article first published online : 22 JUL 2003, DOI: 10.1046/j.1537-2995.2003.00465.x

  9. You have free access to this content
    Index

    Thomas' Hematopoietic Cell Transplantation, Third Edition

    Karl G. Blume, Stephen J. Forman, Frederick R. Appelbaum, Pages: 1511–1563, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987070.index

  10. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning

    Transfusion

    Volume 42, Issue 10, October 2002, Pages: 1293–1301, Nina Worel, Hildegard T. Greinix, Felix Keil, Margit Mitterbauer, Klaus Lechner, Gottfried Fischer, Wolfgang Mayr, Paul Höcker and Peter Kalhs

    Article first published online : 8 OCT 2002, DOI: 10.1046/j.1537-2995.2002.00209.x

  11. You have free access to this content
    The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation

    British Journal of Haematology

    Volume 149, Issue 1, April 2010, Pages: 101–110, Zejing Wang, Mohamed L. Sorror, Wendy Leisenring, Gary Schoch, David G. Maloney, Brenda M. Sandmaier and Rainer Storb

    Article first published online : 11 JAN 2010, DOI: 10.1111/j.1365-2141.2009.08073.x

  12. You have free access to this content
    Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

    Cancer

    Volume 112, Issue 9, 1 May 2008, Pages: 1992–2001, Mohamed Sorror, Barry Storer, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Amelia Langston, Richard T. Maziarz, Michael Pulsipher, Peter A. McSweeney and Rainer Storb

    Article first published online : 29 FEB 2008, DOI: 10.1002/cncr.23375

  13. Histologic Evaluation of Mucocutaneous Graft Versus Host Disease in Nonmyeloablative Hematologic Stem Cell Transplants

    Journal of Cutaneous Pathology

    Volume 32, Issue 1, January 2005, Page: 77, A.T. Bridge, R.P. Nelson, J.E. Schwartz, G.W. Mirowski and S.D. Billings

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.0303-6987.2005.320aa.x

  14. Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 5, November 2005, Pages: 486–500, Pamala Jacobson, John Rogosheske, Juliet N. Barker, Kathleen Green, Juki Ng, Daniel Weisdorf, Ye Tan, Janel Long, Rory Remmel, Ronald Sawchuk and Philip McGlave

    Article first published online : 18 NOV 2005, DOI: 10.1016/j.clpt.2005.08.009

  15. You have free access to this content
    Targeting Cells Causing Split Tolerance Allows Fully Allogeneic Islet Survival With Minimal Conditioning in NOD Mixed Chimeras

    American Journal of Transplantation

    Volume 12, Issue 12, December 2012, Pages: 3235–3245, D. P. Al-Adra, R. Pawlick, A. M. J. Shapiro and C. C. Anderson

    Article first published online : 13 SEP 2012, DOI: 10.1111/j.1600-6143.2012.04260.x

  16. You have free access to this content
    Successful control of Epstein–Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection

    American Journal of Hematology

    Volume 76, Issue 4, August 2004, Pages: 368–372, Taeko Uehara, Chiaki Nakaseko, Satoru Hara, Akane Harima, Megumi Ejiri, Akira Yokota, Yasushi Saito and Miki Nishimura

    Article first published online : 23 JUL 2004, DOI: 10.1002/ajh.20121

  17. Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

    European Journal of Haematology

    Volume 66, Issue 2, February 2001, Pages: 137–139, L. Garderet, H. Bittencourt, A. Kaliski, M. T. Daniel, P. Ribaud, G. Socié and E. Gluckman

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1600-0609.2001.00377.x

  18. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility

    Clinical & Laboratory Haematology

    Volume 27, Issue 3, June 2005, Pages: 206–208, N. J. CURTIN and A. P. SCHWARER

    Article first published online : 7 JUN 2005, DOI: 10.1111/j.1365-2257.2005.00690.x

  19. HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism

    Clinical & Laboratory Haematology

    Volume 27, Issue 2, April 2005, Pages: 139–141, K. IKEGAME, M. KAWAKAMI, T. YAMAGAMI, H. MAEDA, K. ONISHI, Y. TANIGUCHI, T. FUJIOKA, T. MASUDA, I. KAWASE and H. OGAWA

    Article first published online : 18 MAR 2005, DOI: 10.1111/j.1365-2257.2005.00675.x

  20. Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation

    Transplant Infectious Disease

    Volume 6, Issue 4, December 2004, Pages: 171–178, E. Meijer, A.W. Dekker, H.M. Lokhorst, E.J. Petersen, H.K. Nieuwenhuis and L.F. Verdonck

    Article first published online : 11 MAR 2005, DOI: 10.1111/j.1399-3062.2004.00075.x